CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway
Haishu Lv,1 Beibei Zhang,1 Xi Weng,1 Youjia Li,2 Chaoxian Deng,1 Rui Wang,2 Lei Shi,3 Yuanqin Yin1 1Cancer Institute, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, People’s Republic of China; 2Department of Pathology, The Fourth Affiliated Hospital of China...
Saved in:
Main Authors: | Lv H, Zhang B, Weng X, Li Y, Deng C, Wang R, Shi L, Yin Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-05-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cd151-promotes-cancer-progression-in-triple-negative-breast-cancer-by--peer-reviewed-fulltext-article-BCTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond
by: Agelidis A, et al.
Published: (2025-06-01) -
Molecular Markers for Thyroid Cancer Diagnosis: Insights from MAPK Pathway Gene Expression Analysis
by: Breno Pupin, et al.
Published: (2025-06-01) -
Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01) -
Aaptamine Alters Vimentin Expression and Migration Capability of Triple-Negative Breast Cancer Cells
by: Khairani AF, et al.
Published: (2025-05-01) -
Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy
by: Wanjuan Pei, et al.
Published: (2025-07-01)